Rubicon Organics Inc (ROMJF)
0.30
+0.02
(+7.03%)
USD |
OTCM |
May 17, 13:26
Rubicon Organics Profit Margin (Quarterly): -16.37% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -16.37% |
| June 30, 2023 | -1.01% |
| March 31, 2023 | -6.53% |
| December 31, 2022 | -28.73% |
| September 30, 2022 | 19.21% |
| June 30, 2022 | -13.95% |
| March 31, 2022 | -28.97% |
| December 31, 2021 | -23.34% |
| September 30, 2021 | -54.25% |
| June 30, 2021 | -110.9% |
| March 31, 2021 | -97.00% |
| December 31, 2020 | -105.6% |
| September 30, 2020 | -136.3% |
| Date | Value |
|---|---|
| June 30, 2020 | -183.0% |
| March 31, 2020 | -838.7% |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -765.3% |
| June 30, 2018 | -3.94K% |
| March 31, 2018 | -686.9% |
| December 31, 2017 | -690.4% |
| September 30, 2017 | -494.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-838.7%
Minimum
Mar 2020
19.21%
Maximum
Sep 2022
-108.4%
Average
-28.97%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.32% |
| Return on Assets | -9.86% |
| Return on Invested Capital | -11.27% |
| Gross Profit Margin (Quarterly) | 40.48% |
| Operating Margin (Quarterly) | -15.01% |
| Return on Net Operating Assets | -10.63% |